Advanced CRISPR/Cas-based genome editing tools for microbial biofuels production: A review

被引:57
|
作者
Shanmugam, Sabarathinam [1 ,2 ]
Ngo, Huu-Hao [3 ]
Wu, Yi-Rui [1 ,2 ,3 ]
机构
[1] Shantou Univ, Dept Biol, Shantou 515063, Guangdong, Peoples R China
[2] Shantou Univ, Guangdong Prov Key Lab Marine Biotechnol, Shantou 515063, Guangdong, Peoples R China
[3] Univ Technol Sydney, Sch Civil & Environm Engn, Broadway, NSW 2007, Australia
基金
中国国家自然科学基金;
关键词
CRISPR-Cas; Biofuels; Metabolic flux; Gene regulation; Off-target effect; ESCHERICHIA-COLI; CLOSTRIDIUM-ACETOBUTYLICUM; BIOETHANOL PRODUCTION; BIOBUTANOL PRODUCTION; TAL EFFECTORS; CAS9; SPECIFICITY; PATHWAY; CONVERSION; EXPRESSION;
D O I
10.1016/j.renene.2019.10.107
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
With rapid progress in the fields of synthetic biology and metabolic engineering, there are possible applications to generate a wide range of advanced biofuels with maximized yield and productivity to achieve a more sustainable bioprocess with reduced carbon footprints. Among the diverse molecular biology tools, clustered regularly interspaced short palindromic repeats-CRISPR-associated proteins (CRISPR-Cas) technology stands out with potential targeted genome editing, exhibiting a more precise and accurate gene knock-out and knock-in system better than its predecessors, for example zinc finger nucleases (ZFN) and transcription activator-like effector nucleases (TALEN). There are reports involved in the advanced microbial genome engineering tools for the biofuels production; however, there is lack of a comprehensive review about the CRISPR-Cas based-techniques in improved biofuel production along with the strategies to reduce the off-target effect that ensures the success and safety of this method. Therefore, in this review we attempt to systematically comment on the mechanism of CRISPR-Cas and its application to microbial biofuels production. This includes bioethanol, biobutanol as well as other hydrocarbons that sequentially follow various suggestions on enhancing the efficiency of targeting genes. The role of inducible on/off genetic circuits in response to environmental stimuli in the regulation of targeted genome editing (TGE) by minimizing metabolic burden and maximizing fermentation efficiency is also discussed. The relevant stringent regulatory demands to ensure minimal off-target cleavage with maximum efficiency coupled with complete biosafety of this technology are considered. It can be concluded that the recent development of CRISPR-Cas technology should open a new avenue in creating microbial biorefineries for potentially enhanced biofuel production. (C) 2019 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1107 / 1119
页数:13
相关论文
共 50 条
  • [21] Recent Research Trends in Stem Cells Using CRISPR/Cas-Based Genome Editing Methods
    Yoon, Da Eun
    Lee, Hyunji
    Kim, Kyoungmi
    INTERNATIONAL JOURNAL OF STEM CELLS, 2024, 17 (01) : 1 - 14
  • [22] Dimeric CRISPR/Cas-based nucleases for high-precision genome editing in human cells
    Tsai, Shengdar Q.
    Wyvekens, Nicolas
    Khayter, Cyd
    Foden, Jennifer A.
    Thapar, Vishal
    Reyon, Deepak
    Goodwin, Mathew J.
    Aryee, Martin J.
    Joung, J. Keith
    HUMAN GENE THERAPY, 2014, 25 (11) : A120 - A121
  • [23] CRISPR/Cas-based tools for the targeted control of plant viruses
    Robertson, Gaelle
    Burger, Johan
    Campa, Manuela
    MOLECULAR PLANT PATHOLOGY, 2022, 23 (11) : 1701 - 1718
  • [24] Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for In Vivo CRISPR/Cas-Based Genome Editing
    Wei, Tuo
    Cheng, Qiang
    Farbiak, Lukas
    Anderson, Daniel G.
    Langer, Robert
    Siegwart, Daniel J.
    ACS NANO, 2020, 14 (08) : 9243 - 9262
  • [25] An overview: CRISPR/Cas-based gene editing for viral vaccine development
    Bhujbal, Santosh
    Bhujbal, Rushikesh
    Giram, Prabhanjan
    EXPERT REVIEW OF VACCINES, 2022, 21 (11) : 1581 - 1593
  • [26] CRISPR/Cas-Based Epigenome Editing: Advances, Applications, and Clinical Utility
    Goell, Jacob H.
    Hilton, Isaac B.
    TRENDS IN BIOTECHNOLOGY, 2021, 39 (07) : 678 - 691
  • [27] CRISPR/Cas-Based Modifications for Therapeutic Applications: A Review
    Bharathkumar, Nagaraj
    Sunil, Abraham
    Meera, Prabhakar
    Aksah, Sam
    Kannan, Muthu
    Saravanan, Konda Mani
    Anand, Thirunavukarasou
    MOLECULAR BIOTECHNOLOGY, 2022, 64 (04) : 355 - 372
  • [28] CRISPR/CAS9, the king of genome editing tools
    A. V. Bannikov
    A. V. Lavrov
    Molecular Biology, 2017, 51 : 514 - 525
  • [29] TALEN and CRISPR/Cas Genome Editing Systems: Tools of Discovery
    Nemudryi, A. A.
    Valetdinova, K. R.
    Medvedev, S. P.
    Zakian, S. M.
    ACTA NATURAE, 2014, 6 (03): : 19 - 40
  • [30] CRISPR/CAS9, the King of Genome Editing Tools
    Bannikov, A. V.
    Lavrov, A. V.
    MOLECULAR BIOLOGY, 2017, 51 (04) : 514 - 525